ROSEN, A LEADING LAW FIRM, Encourages PepGen Inc. Investors to Secure Counsel Before Important ...
NEW YORK, UNITED STATES, JUL 25 – Rosen Law Firm highlights false claims about PepGen's drug PGN-EDO51 and urges investors to act before the August 8 deadline to seek lead plaintiff status.
Summary by Denver Gazette
3 Articles
3 Articles


ROSEN, A LEADING LAW FIRM, Encourages PepGen Inc. Investors to Secure Counsel Before Important ...
NEW YORK, July 24, 2025 (GLOBE NEWSWIRE) -
·Denver, United States
Read Full ArticleCoverage Details
Total News Sources3
Leaning Left1Leaning Right0Center2Last UpdatedBias Distribution67% Center
Bias Distribution
- 67% of the sources are Center
67% Center
L 33%
C 67%
Factuality
To view factuality data please Upgrade to Premium